Recent investigations into the role of MYB in human leukemia have pin-pointed MYB as a potential drug target for AML and have stimulated research in the use of low-molecular-weight compounds as potential MYB inhibitors. The gene discussed is MYB; the disease is acute myeloid leukemia.